1.20
0.02 (1.69%)
0.02 (1.69%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Outlook Therapeutics Inc | OTLK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.04 | -3.28% | 1.18 | 1.17 | 1.30 | 1.20 | 1.22 | 16:10:55 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.18 | 1.20 | 0.02 | 1.67% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,504 | 1,355,965 | $ 1.21 | $ 1,634,469 | 1,150,848 | 0.4011 - 2.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:14:44 | formt | 250 | $ 1.20 | USD |
Outlook Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 107.83M | 91.38M | 80.77M | $ 8.15M | $ - | -2.42 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 10.00 | 11.80% |
Outlook Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OTLK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.96 | 1.42 | 0.93 | 1.20 | 2,738,059 | 0.22 | 22.92% |
| 1 Month | 0.71 | 1.42 | 0.6909 | 1.00 | 1,913,345 | 0.47 | 66.2% |
| 3 Months | 0.6098 | 1.42 | 0.499 | 0.8726385 | 952,363 | 0.5702 | 93.51% |
| 6 Months | 1.36 | 1.42 | 0.4011 | 0.8737863 | 935,082 | -0.18 | -13.24% |
| 1 Year | 2.36 | 2.89 | 0.4011 | 1.37 | 784,728 | -1.18 | -50.0% |
| 3 Years | 5.60 | 20.00 | 0.4011 | 2.13 | 1,349,985 | -4.42 | -78.93% |
| 5 Years | 5.60 | 20.00 | 0.4011 | 2.13 | 1,349,985 | -4.42 | -78.93% |
Outlook Therapeutics Description
| Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. |
